Finance ministers from the Group of Eight major industrialized powers, who met here this weekend, expect to approve a pilot project when they next get together, in Washington in April.
Under an advance market commitment plan, the G-8 nations would promise to subsidize the purchase of new vaccines -- for between $800 million and $6 billion -- if pharmaceuticals companies develop ones that meet standards of efficacy and safety. Once the G-8 spends the pledged amount, the drug companies would sell the vaccine at a set discount in the developing world.
The idea is to ensure that companies get a substantial, upfront, government-backed financial incentive to develop the drugs, even if they ultimately have to sell them at a low price. 'By restoring appropriate incentives,' advance market commitments 'can stimulate private research and investment, accelerate the discovery of new vaccines, save lives and contribute to economic development in a cost-effective way,' Italian Finance Minister Giulio Tremonti wrote in a report to his G-8 colleagues in December.
Advised by the World Bank and other outside experts, G-8 negotiators are working through details, including which of six Third World killers should be the test case: HIV/AIDS; malaria; tuberculosis; pneumococcus, a source of pneumonia and meningitis; rotavirus, which causes fatal diarrhea in children; or human papillomavirus, a cause of cervical cancer."
No comments:
Post a Comment